A meta-analysis comprising 2,903 ovarian cancer patients showed that intraepithelial CD3+ and CD8+ TILs are closely related to improved PFS, disease-free survival, and OS (Li et al., 2017b). This evidence concerns the gene CD8A and ovarian carcinoma.